Iovance Biotherapeutics files Form 8-K
Iovance Biotherapeutics filed a Form 8-K on October 29.
Related stories
FOKUS 3-BP Reports Record Third-Quarter Profit
M impact | EQUITY | Oct 30, 2026, 08:51 AM UTC
BP reports record $8.46 billion third-quarter profit, beats forecasts
M impact | EQUITY | Oct 30, 2026, 08:49 AM UTC
Intel Reports Third-Quarter Profit; Shares Fall on Weak Outlook
Intel reported a profit for the third quarter, while its shares fell amid weak projections.
M impact | EQUITY | Oct 30, 2026, 08:43 AM UTC
2CRSI Shares Fall 11.4% After Independent Expert Conclusions Published
2CRSI published conclusions from an independent expert appointed following a Grizzly Research report.
M impact | EQUITY | Oct 30, 2026, 08:41 AM UTC
China Stocks Post Biggest Monthly Loss Since 2016 on AI Selloff
China’s blue-chip CSI fell 1.4% Friday to close near a one-year low, while the Shanghai Composite shed 1.4%. The indexes recorded their steepest monthly loss since early 2016 as a
H impact | EQUITY | Oct 30, 2026, 08:40 AM UTC
Amazon Shares Fall 7.3% in Premarket Trading
Amazon shares fell 7.3% in premarket trading after its fourth-quarter sales outlook came in below estimates and AI investment deepened cash burn.
M impact | EQUITY | Oct 30, 2026, 08:37 AM UTC